BioCentury | Dec 3, 2012
Financial News

Rib-X completes venture financing

Rib-X Pharmaceuticals Inc. , New Haven, Conn. Business: Infectious Date completed: 11/29/12 Type: Venture financing Raised: $18.7 million Investors: Vatera Healthcare Partners; Warburg Pincus; ABS Ventures; Vox Equity Partners Note: Rib-X raised $18.7 million in the...
BioCentury | Dec 3, 2012
Finance

GAIN avoids IPO pain

After postponing its IPO in May due to market conditions, Rib-X Pharmaceuticals Inc. turned back to the private markets. The company's new cash infusion should get it to a Phase III data event for its...
BioCentury | Nov 30, 2012
Financial News

Rib-X raises $18.7 million

Rib-X Pharmaceuticals Inc. (New Haven, Conn.) raised $18.7 million in the first tranche of a planned $67.5 million venture round led by new investor Vatera Healthcare Partners. Existing investors Warburg Pincus; ABS Ventures; and Vox...
BioCentury | Jan 27, 2009
Financial News

Rib-X raises $25 million

...ABS Ventures; Axiom Ventures; EuclidSR Partners; MedImmune Ventures; Oxford Bioscience Partners; S.R. One; and Vox Equity Partners I...
BioCentury | Apr 7, 2008
Finance

Ebb & Flow

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went...
Items per page:
1 - 5 of 5
BioCentury | Dec 3, 2012
Financial News

Rib-X completes venture financing

Rib-X Pharmaceuticals Inc. , New Haven, Conn. Business: Infectious Date completed: 11/29/12 Type: Venture financing Raised: $18.7 million Investors: Vatera Healthcare Partners; Warburg Pincus; ABS Ventures; Vox Equity Partners Note: Rib-X raised $18.7 million in the...
BioCentury | Dec 3, 2012
Finance

GAIN avoids IPO pain

After postponing its IPO in May due to market conditions, Rib-X Pharmaceuticals Inc. turned back to the private markets. The company's new cash infusion should get it to a Phase III data event for its...
BioCentury | Nov 30, 2012
Financial News

Rib-X raises $18.7 million

Rib-X Pharmaceuticals Inc. (New Haven, Conn.) raised $18.7 million in the first tranche of a planned $67.5 million venture round led by new investor Vatera Healthcare Partners. Existing investors Warburg Pincus; ABS Ventures; and Vox...
BioCentury | Jan 27, 2009
Financial News

Rib-X raises $25 million

...ABS Ventures; Axiom Ventures; EuclidSR Partners; MedImmune Ventures; Oxford Bioscience Partners; S.R. One; and Vox Equity Partners I...
BioCentury | Apr 7, 2008
Finance

Ebb & Flow

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went...
Items per page:
1 - 5 of 5